QQ客服 官方微博 反馈留言

浏览/检索结果: 共14条，第1-10条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文 CANCER MEDICINE, 2022 作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan 收藏  |  浏览/下载：18/0  |  提交时间：2022/12/23 EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome   clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma (vol 11, pg 420, 2022) 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2022 作者:  Xu, Xiaoling;  Shen, Wenming;  Wang, Ding;  Li, Na;  Huang, Zhiyu 收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23 Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma 期刊论文 JOURNAL OF ONCOLOGY, 2022, 卷号: 2022 作者:  Liu, Xin;  Fu, Meng;  Xia, Daqing;  Ji, Zimei;  Hu, Nana 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22 Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Xu, X.;  Li, N.;  Fan, Y. 收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23 ALK  non-small cell lung cancer (NSCLC)  leptomeningeal metastases (LM)   Gene expression profile of human colorectal cancer identified NKTR as a biomarker for liver metastasis 期刊论文 AGING-US, 2022, 卷号: 14 作者:  Bai, Rui;  Shi, Zhong;  Li, Dan;  Zhou, Donger;  Ge, Wei-Ting 收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23 colorectal cancer  liver metastasis  NKTR  proliferation  migration and invasion   Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report 期刊论文 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Fu, Meng;  Feng, Chun-Mei;  Xia, Da-Qing;  Ji, Zi-Mei;  Xia, Huai-Ling 收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23 savolitinib  MET exon 14 skipping  neoadjuvant therapy  non-small cell lung cancer  targeted therapy   Targeting KRAS mutant cancers: from druggable therapy to drug resistance 期刊论文 MOLECULAR CANCER, 2022, 卷号: 21 作者:  Zhu, Chunxiao;  Guan, Xiaoqing;  Zhang, Xinuo;  Luan, Xin;  Song, Zhengbo 收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23 KRAS mutations  Druggable  Resistance  Combination therapy   Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11 作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan 收藏  |  浏览/下载：13/0  |  提交时间：2022/12/22 Non-small cell lung cancer (NSCLC)  HIVEP1-ALK  alectinib  intergenic region (IGR)  case report   Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer 期刊论文 DISCOVER ONCOLOGY, 2022, 卷号: 13 作者:  Lv, Yang;  Lin, Wenchu 收藏  |  浏览/下载：12/0  |  提交时间：2022/12/23 Lung cancer  CHD family  Prognosis  Bioinformatics analysis  Immune infiltrates   Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer 期刊论文 JOURNAL OF ONCOLOGY, 2022, 卷号: 2022 作者:  Li, Yue;  Li, Chong;  Jiang, Ya;  Han, Xue;  Liu, Sisi 收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23